Relation with OMICS Sciences
Genomics, Proteomics and Bioinformatics are all from the field of OMICS sciences, which revolve around Transcriptomics. Disruptions or changes at any step of gene expression are responsible for many genetic diseases. Through the use of Genome Analysis and Microarrays scientists can determine – in a single experiment – the expression levels of hundreds or thousands of genes within a cell. All these genome sequence data can be recalled Big Data Mining. Other field of genomics related to sequence analysis is Functional Genomics, Computational Genetics, Comparative Genomics, Translational Genomics, and Evolutionary Genomics.
Molecular evidence from a sequence-based application is a main agenda in Plant Genomics and Microbial Genomics. For a higher resolution of cellular differences and a better understanding of the function of an individual cell in the context of its microenvironment, Single Cell Genome sequencing is done which examines the sequence information from individual cells with optimized next generation sequencing (NGS) technologies. For more information about the products (proteins) of these cells, it is mandatory to understand the mechanism involved in their transcription and translation. In that case Proteomics of Transcription Machinery, proving itself helpful in explaining the expression of proteins by through ribosome in a Single cell. Coming to the Bioinformatics, the major breakthrough involves Drug designing and Drug Discovery, making the entire process more fast at quite low cost.
Genomic labs have the fastest growing market with nearly 250 universities concentrating on its research majorly to be named Whitetail Genetic Research Institute, Stanford University, National Human Genome Research Institute. Major companies concentrating on the research are Affymetrix, Applied Biosystems, Foster City, and Genentech etc. Drug Discovery research has the major growing market with applications in pharmaceuticals and medicine and thus major companies like Bristol-Myers Squibb Company, Isis Pharmaceuticals, Inc. , Merck & Co. Inc. and Johnson & Johnson focusing on the growing industry.
Relevant Conferences:
6th International Conference on Genomics & Pharmacogenomics, September 22-24, 2016 Berlin, Germany; 6th International Conference & Expo on Proteomics March 29-30, 2016 Atlanta, USA; 6th International Conference on Bioinformatics March 29-30, 2016 Valencia, Spain; 5th International Conference and Exhibition on Metabolomics May 16-18, 2016, Osaka, Japan; International Conference on Next Generation Sequencing, July 21-22, 2016, Berlin, Germany; Genomic Instability, July 23-24, 2016, Hong Kong, China; 18th International Conference on Proteomics and Bioinformatics, March 30 - 31, 2016, Istanbul, Turkey; X Annual Congress of the European Proteomics Association, June 21-25, 2016 Istanbul, Turkey; 7th International Conference on Bioinformatics Models, Methods and Algorithms, February 21-23, 2016, Rome, Italy; The Fourteenth Asia Pacific Bioinformatics Conference, January 11-13, 2016, San Francisco, USA.
- Genome Transcription
- Big Data Mining
- Functional Genomics
- Computational Genetics
- Comparative Genomics
- Translational Genomics
- Evolutionary Genomics
- Plant Genomics
- Microbial Genomics
- Proteomics of Transcription Machinery
Related Conference of Relation with OMICS Sciences
3rd Conference on Protein and Proteomics
Quantitative Proteomics and Data Analysis
FEBS Workshop on Chromatin Proteomics
International Conference on Proteomics in Cell Biology and Disease Mechanisms
International Conference on Genome Editing and Gene Modulation Congress
International Conference on Genome Editing and Engineering
International Conference on Epitranscriptome
International Conference on Metabolism Transcription and Disease
Plant Genomics Congress
18th International Conference on Proteomics and Bioinformatics
International Conference on Transcription and Chromatin
7th International Conference on Bioinformatics Models Methods and Algorithms
The Fourteenth Asia Pacific Bioinformatics Conference
Genomic Instability
International Conference on Understanding the Function of Human Genome Variation
Relation with OMICS Sciences Conference Speakers
Recommended Sessions
- Cancer Transcriptomics: Integrative & Computational Approaches
- Clinical Applications & Related Disorders
- Diagnosis & Applications of RNA-Seq
- Epigenetics
- Exploring Transcriptome
- Expression Profiling
- Human Transcriptomics
- NGS Technologies
- Ocular Transcriptomics
- Relation with OMICS Sciences
- RNA Editing & Interference: Interplay
- Single Cell Transcriptomics
- Transcriptional Regulation & Attenuation
- Transcriptome analysis & Gene Expression
- Transcriptome Technologies Market
- Transcriptomics & Proteomics in Microorganisms
- Transcriptomics & Proteomics in Plants
- Transcriptomics Case Reports
Related Journals
Are you interested in
- 3D Structure Determination - Structural Biology-2026 (France)
- Advanced Drug Delivery Systems for Metabolic Therapy - DRUG CHEMISTRY CONF 2026 (France)
- Advanced Techniques in Structural Biology - Structural Biology-2026 (France)
- AI & Computational Structural Biology - Structural Biology-2026 (France)
- Biochemistry and Biophysics - Structural Biology-2026 (France)
- Biomarker-Guided Drug Development - DRUG CHEMISTRY CONF 2026 (France)
- Chemical Biology Tools in Metabolic Research - DRUG CHEMISTRY CONF 2026 (France)
- Computational Approach in Structural Biology - Structural Biology-2026 (France)
- Computational Drug Design and Molecular Modeling - DRUG CHEMISTRY CONF 2026 (France)
- Drug Designing and Biomarkers - Structural Biology-2026 (France)
- Drug Resistance and Therapeutic Durability - DRUG CHEMISTRY CONF 2026 (France)
- Enzyme Modulation Approaches in Antidiabetic Drug Design - DRUG CHEMISTRY CONF 2026 (France)
- Epigenetic Regulation and Small-Molecule Therapeutics - DRUG CHEMISTRY CONF 2026 (France)
- Future Directions in Drug Chemistry for Diabetes Management - DRUG CHEMISTRY CONF 2026 (France)
- Hybrid Approaches for Structure Prediction - Structural Biology-2026 (France)
- Lipid Chemistry and Metabolic Regulation - DRUG CHEMISTRY CONF 2026 (France)
- Medicinal Chemistry Strategies for Metabolic Disorders - DRUG CHEMISTRY CONF 2026 (France)
- Membrane Proteins and Receptors - Structural Biology-2026 (France)
- Molecular Modelling and Dynamics - Structural Biology-2026 (France)
- Natural Product Chemistry in Diabetes Drug Discovery - DRUG CHEMISTRY CONF 2026 (France)
- Oxidative Stress Modulation through Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Peptide and Protein-Based Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Pharmacokinetics and Drug Metabolism Studies - DRUG CHEMISTRY CONF 2026 (France)
- Prodrug Design and Chemical Activation Strategies - DRUG CHEMISTRY CONF 2026 (France)
- Proteomics and Genomics - Structural Biology-2026 (France)
- Regulatory Chemistry and Drug Safety Assessment - DRUG CHEMISTRY CONF 2026 (France)
- Structural Bioinformatics and Computational Biology - Structural Biology-2026 (France)
- Structural Biology in Cancer Research - Structural Biology-2026 (France)
- Structural Virology - Structural Biology-2026 (France)
- Structural Virology and Infectious Diseases - Structural Biology-2026 (France)
- Structure-Based Drug Discovery - Structural Biology-2026 (France)
- Structure-Based Solutions to Global Health Challenges - Structural Biology-2026 (France)
- Structure-Function Relationships - Structural Biology-2026 (France)
- Structure–Activity Relationship Studies in Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Synthetic Chemistry Innovations in Drug Development - DRUG CHEMISTRY CONF 2026 (France)
- Targeting Pancreatic Function through Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- The Structural Basis of Disease - Structural Biology-2026 (France)
- Translational Drug Chemistry from Bench to Clinic - DRUG CHEMISTRY CONF 2026 (France)
